These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 2883654

  • 1. Opposing effects of a ras oncogene on growth factor-stimulated phosphoinositide hydrolysis: desensitization to platelet-derived growth factor and enhanced sensitivity to bradykinin.
    Parries G, Hoebel R, Racker E.
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2648-52. PubMed ID: 2883654
    [Abstract] [Full Text] [Related]

  • 2. NIH-3T3 cells transformed by the EJ-ras oncogene exhibit reduced platelet-derived growth factor-mediated Ca2+ mobilization.
    Benjamin CW, Connor JA, Tarpley WG, Gorman RR.
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4345-9. PubMed ID: 3288991
    [Abstract] [Full Text] [Related]

  • 3. Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene.
    Benjamin CW, Tarpley WG, Gorman RR.
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):546-50. PubMed ID: 3099298
    [Abstract] [Full Text] [Related]

  • 4. Phosphoinositide hydrolysis in Ki-ras-transformed fibroblasts stimulated by platelet-derived growth factor and bradykinin.
    Kumada T, Banno Y, Miyata H, Nozawa Y.
    Int J Biochem; 1994 Aug; 26(8):1049-54. PubMed ID: 8088415
    [Abstract] [Full Text] [Related]

  • 5. Alterations of G-protein coupling function in phosphoinositide signaling pathways of cells transformed by ras and other membrane-associated and cytoplasmic oncogenes.
    Alonso T, Srivastava S, Santos E.
    Mol Cell Biol; 1990 Jun; 10(6):3117-24. PubMed ID: 2160594
    [Abstract] [Full Text] [Related]

  • 6. Modified kinetics of platelet-derived growth factor-induced Ca2+ increases in NIH-3T3 cells overexpressing phospholipase C gamma 1.
    Renard DC, Bolton MM, Rhee SG, Margolis BL, Zilberstein A, Schlessinger J, Thomas AP.
    Biochem J; 1992 Feb 01; 281 ( Pt 3)(Pt 3):775-84. PubMed ID: 1536654
    [Abstract] [Full Text] [Related]

  • 7. Lipid signalling pathways in normal and ras-transfected NIH/3T3 cells.
    Matyas GR, Fishman PH.
    Cell Signal; 1989 Feb 01; 1(4):395-404. PubMed ID: 2561989
    [Abstract] [Full Text] [Related]

  • 8. Bradykinin stimulates DNA synthesis in competent Balb/c 3T3 cells and enhances inositol phosphate formation induced by platelet-derived growth factor.
    Godin C, Smith AD, Riley PA.
    Biochem Pharmacol; 1991 Jun 21; 42(1):117-22. PubMed ID: 2069585
    [Abstract] [Full Text] [Related]

  • 9. Glucose and scyllo-inositol impair phosphoinositide hydrolysis in the 10.5-day cultured rat conceptus: a role in dysmorphogenesis?
    Strieleman PJ, Metzger BE.
    Teratology; 1993 Sep 21; 48(3):267-78. PubMed ID: 8248864
    [Abstract] [Full Text] [Related]

  • 10. EJ-Ras inhibits phospholipase C gamma 1 but not actin polymerization induced by platelet-derived growth factor-BB via phosphatidylinositol 3-kinase.
    Heldman AW, Kandzari DE, Tucker RW, Crawford LE, Fearon ER, Koblan KS, Goldschmidt-Clermont PJ.
    Circ Res; 1996 Feb 21; 78(2):312-21. PubMed ID: 8575075
    [Abstract] [Full Text] [Related]

  • 11. Early changes in inositol lipids and their metabolites induced by platelet-derived growth factor in quiescent Swiss mouse 3T3 cells.
    Hasegawa-Sasaki H.
    Biochem J; 1985 Nov 15; 232(1):99-109. PubMed ID: 3936489
    [Abstract] [Full Text] [Related]

  • 12. NIH-3T3 cells expressing high levels of the c-ras proto-oncogene display reduced platelet derived growth factor-stimulated phospholipase activity.
    Olinger PL, Gorman RR.
    Biochem Biophys Res Commun; 1988 Feb 15; 150(3):937-41. PubMed ID: 3422559
    [Abstract] [Full Text] [Related]

  • 13. Bombesin and platelet-derived growth factor stimulate formation of inositol phosphates and Ca2+ mobilization in Swiss 3T3 cells by different mechanisms.
    Blakeley DM, Corps AN, Brown KD.
    Biochem J; 1989 Feb 15; 258(1):177-85. PubMed ID: 2930505
    [Abstract] [Full Text] [Related]

  • 14. Repression of platelet-derived growth factor beta-receptor expression by mitogenic growth factors and transforming oncogenes in murine 3T3 fibroblasts.
    Vaziri C, Faller DV.
    Mol Cell Biol; 1995 Mar 15; 15(3):1244-53. PubMed ID: 7862118
    [Abstract] [Full Text] [Related]

  • 15. Bradykinin binding to B2 kinin receptors and stimulation of phosphoinositide turnover and arachidonic acid release in primary cultures of cells from late pregnant rat myometrium.
    Tropea MM, Munoz CM, Leeb-Lundberg LM.
    Can J Physiol Pharmacol; 1992 Oct 15; 70(10):1360-71. PubMed ID: 1337013
    [Abstract] [Full Text] [Related]

  • 16. Regulation of Na+-H+ exchange in normal NIH-3T3 cells and in NIH-3T3 cells expressing the ras oncogene.
    Owen NE, Knapik J, Strebel F, Tarpley WG, Gorman RR.
    Am J Physiol; 1989 Apr 15; 256(4 Pt 1):C756-63. PubMed ID: 2539724
    [Abstract] [Full Text] [Related]

  • 17. Desensitization of the Ca2+-mobilizing system to serum growth factors by Ha-ras and v-mos.
    Maly K, Doppler W, Oberhuber H, Meusburger H, Hofmann J, Jaggi R, Grunicke HH.
    Mol Cell Biol; 1988 Oct 15; 8(10):4212-6. PubMed ID: 3141785
    [Abstract] [Full Text] [Related]

  • 18. Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene.
    Lin AH, Groppi VE, Gorman RR.
    Mol Cell Biol; 1988 Nov 15; 8(11):5052-5. PubMed ID: 3145405
    [Abstract] [Full Text] [Related]

  • 19. Effects of ras-encoded proteins and platelet-derived growth factor on inositol phospholipid turnover in NRK cells.
    Kamata T, Kung HF.
    Proc Natl Acad Sci U S A; 1988 Aug 15; 85(16):5799-803. PubMed ID: 2842749
    [Abstract] [Full Text] [Related]

  • 20. Preferential inhibition of the platelet-derived growth factor receptor tyrosine kinase by staurosporine.
    Secrist JP, Sehgal I, Powis G, Abraham RT.
    J Biol Chem; 1990 Nov 25; 265(33):20394-400. PubMed ID: 2173705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.